|
MAJOR
RESEARCH PROJECT AREAS
Targeting
inflammatory cytokines and
adhesion molecules.
During the past
sixten years, Dr
Habtemariam has developed
several in vitro
bioassay methods for screening
potential antagonist of
proinflammatory cytokines
(e.g. TNF), cell adhesion
molecule (integrins &
immunoglobulins), endotoxin,
etc. By using these bioassays,
he has identified
several promising natural
small molecular weight
antiinflammartory agents [see
under publications].
His
expertise in this area
include measurements of
inflammatory cytokines
release, cytokines mediated
apoptosis/proliferation,
inhibitors of adhesion
molecules
expression/activation and
cell-cell and cell-protein
adhesion.
Search for
anti-microbial agents. An
in vitro assay model
for routine screening of
drugs against the mammalian
stage of leishmania (protozoa)
parasites has been
developed and some promising
compounds have already
been identified. We are
currently testing natural
products for antiviral
activities - particularly
anti-HSV-1 and anti-HSV-2
effects. Drugs are also
routinely screened for their
effects on bacteria, yeast and
fungi. The agar-disc
diffusion method and MIC
measurements are routinely
used for these studies
[see under publications].
In vitro anticancer
and immunomodulatory
activity evaluations.
Dr Habtemariam has over
ten years of experience in the
use of primary cultures
and established cell lines for
anticancer activity studies.
The cytotoxic/cytostatic
effects of drugs together with
assessment of apoptosis
(programmed cell death) events
are routinely measured [see
under publications].
Purification/isolation
and spectroscopic analysis
of drug candidates.
Following the bioassay of
crude drugs (herbal drugs,
snake venom or synthetic
mixtures), various
chromatographic (TLC, LP- and
HPLC, etc.) techniques are
used to isolate active
principles. The identity of
active principles are
characterised by spectroscopic
techniques such as IR, UV, MS
and 1D and 2D-NMR spectroscopy
[see under publications].
Reactive
Oxygen Species in Health
and Disease -
WE ARE CURRENTLY STUDYING
THE ANTIOXIDANT, PROOXIDANT
AND CHEMO/CYTOPROTECTIVE
PROPERTIES OF MEDICINAL
PLANTS AND THEIR METABOLITES
USING VARIOUS IN-HOUSE
CHEMICAL AND BIOLOGICAL
ASSAY SYSTEMS. WE ARE
PARTICULARLY INTERESTED IN
ASSESSING THE
NEUROPROTECTIVE EFFECTS OF
NATURAL PRODUCTS
[see under publications].
Enzyme
inhibition studies
- We have recently
incorporated enzyme inhibition
studies in our bioassay
screens for disease models
including Alzheimer's,
diabetes and inflammatory
conditions.
Other
areas of interest include
neurodegenerative disease,
diabetes and COVID-19 - see
menus on the left.
We offer
teaching/training,
collaborative research and a
range of consultancy Services
in this field.
Pharmacognosy
Research and Herbal Analysis
Services UK Ltd
A
company registered in
England and Wales - Company
Number: 16773437
Registered
office: 124 City Road, London,
EC1V 2NX, United Kingdom
The use of our
website contents, products
and/or services are with
your agreement to our terms
of use and disclaimer 
Home
.................We value
your feedback..................
FOLLOW US ALSO ON THE
FOLLOWING:

|